Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

16 1 Search for Universal Tumor-Associated T Cell Epitopes
52 Molldrem, J., Dermime, S., Parker, K.,
Jiang,Y. Z., Mavroudis, D., Hensel, N.,
Fukushima, P. and Barrett, A. J. Targeted
T-cell therapy for human leukemia:
cytotoxic T lymphocytes specific for
a peptide derived from proteinase 3 preferentially
lyse human myeloid leukemia
cells, Blood 88: 2450±7, 1996.
53 Gaiger, A., Reese,V., Disis, M. L. and
Cheever, M. A. Immunity to WT1 in
the animal model and in patients with
acute myeloid leukemia, Blood 96: 1480±
9, 2000.
54 Tsang, K. Y., Zaremba, S., Nieroda,
C. A., Zhu, M. Z., Hamilton, J. M. and
Schlom, J. Generation of human cytotoxic
T cells specific for human carcinoembryonic
antigen epitopes from patients
immunized with recombinant vaccinia-CEA
vaccine, JNatl Cancer Inst 87:
982±90, 1995.
55 Correale, P.,Walmsley, K., Zaremba, S.,
Zhu, M., Schlom, J. and Tsang, K. Y.
Generation of human cytolytic T lymphocyte
lines directed against prostate-specific
antigen (PSA) employing a PSA oligoepitope
peptide, JImmunol 161: 3186±
94, 1998.
56 Ioannides, C. G., Fisk, B., Jerome,
K. R., Irimura, T.,Wharton, J. T. and
Finn, O. J. Cytotoxic T cells from ovarian
malignant tumors can recognize polymorphic
epithelial mucin core peptides,
JImmunol 151: 3693±703, 1993.
57 Brossart, P., Heinrich, K. S., Stuhler,
G., Behnke, L., Reichardt,V. L.,
Stevanovic, S., Muhm, A., Rammensee,
H. G., Kanz, L. and Brugger,W. Identification
of HLA-A2-restricted T-cell epitopes
derived from the MUC1 tumor
antigen for broadly applicable vaccine
therapies, Blood 93: 4309±17, 1999.
58 Peoples, G. E., Anderson, B. W., Lee,
T. V., Murray, J. L., Kudelka, A. P.,
Wharton, J. T. and Ioannides, C. G.
Vaccine implications of folate binding
protein, a novel cytotoxic T lymphocyterecognized
antigen system in epithelial
cancers, Clin Cancer Res 5: 4214±23,
1999.
59 Trojan, A.,Witzens, M., Schultze, J. L.,
Vonderheide, R. H., Harig, S., Krackhardt,
A. M., Stahel, R. A. and Gribben,
J. G. Generation of cytotoxic T lymphocytes
against native and altered peptides
of human leukocyte antigen-
A*0201 restricted epitopes from the human
epithelial cell adhesion molecule,
Cancer Res 61: 4761±5, 2001.